Selected Publications

Narayan, V.; Keefe, S.; Haas, NB.; Wang, L.; Puzanov, I.; Putt, M.; Catino, A.; Fang, J.; Agarwal, N.; Hyman, D.; Smith, AM.; Finkelman, B.; Narayan, HK.; Ewer, S.; ElAmm, C.; Lenihan, D.; Ky, B.: Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma. Clin Cancer Res 23(14): 3601-3609, July 2017.

Narayan, V.; Barber-Rotenberg, J.S.; Jung, I-Y.; Lacey, SF.; Rech, AJ.; Davis, MM.; Hwang, W-T.; Lal, P.; Carpenter, EL.; Maude, SL.; Plesa, G.; Vapiwala, N.; Chew, A.; Moniak, M.; Sebro, RA.; Farwell, MD.; Marshall, A.; Gilmore, J.; Lledo, L.; Dengel, K.; Church, SE.; Hether, TD.; Xu, J.; Gohil, M.; Buckingham, TH.; Yee, SS.; Gonzalez, VE.; Kulikovskaya, I.; Chen, F.; Tian, L.; Tien, K.; Gladney, W.; Nobles, CL.; Raymond, H.; Prostate Cancer Cellular Therapy Program Investigators, Hexner, EO.; Siegel, DL.; Bushman, FD.; June, CH.; Fraietta, JA.; Haas, NB. : PSMA-targeting TGFβ-insensitive Armored CAR T-cells in Metastatic Castration Resistant Prostate Cancer: a Phase 1 Trial. Nat Med 28(4): 724-734, Apr 2022.

Dorff, TB.;* Narayan, V.;* Forman, SJ.; Zang, PD.; Fraietta, JA.; June, CH.; Haas, NB.; Priceman, SJ.: Novel Redirected T Cell Immunotherapies for Advanced Prostate Cancer. Clin Cancer Res 28(4): 576-584, Oct 2021 Notes: * Co-First Authors (In Press).

Jonasch, E.; Donskov, F.; Iliopoulos, O.; Rathmell, WK.; Narayan, V.; Maughan, BL.; Oudard, S.; Else, T.; Maranchie, JK.; Welsh, SJ.; Thamake, S.; Park, EK.; Perini, RF.; Linehan, WM.; Srinivasan, R.: Belzutifan for Von Hippel-Lindau Disease–Associated Renal Cell Carcinoma. New Engl J Medicine 385(22): 2036-2046, Nov 2021.

Pal, SK.; Tangen, C.; Thompson, IM.; Haas, NB.; George, DJ.; Heng, D.; Shuch, B.; Stein, M.; Tretiakova, M.; Humphrey, P.; Adeniran, A.; Narayan, V.; Bjarnason, G.; Vaishampayan, U.; Alva, A.; Zhang, T.; Cole, S.; Plets, M.; Wright, J.; Lara, P. : A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial. Lancet. (eds.). 397(10275): 695-703, Feb 2021.

Sharma, P.; Pachynski, RK.; Narayan, V.; Fléchon, A.; Gravis, G.; Galsky, M.; Mahammedi, H.; Patnaik, A.; Subudhi, SK.; Ciprotti, M.; Simsek, B.; Saci, A.; Hu, Y.; Han, GC.; Fizazi, K. : Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial. Cancer Cell 38(4): 489-499, Oct 2020.

Narayan, V.; Harrison, M.; Cheng, H.; Kenfield, S.; Aggarwal, R.; Kwon, D.; McKay, R.; Hauger, R.; Hart, N.; Conzen, S.; Borno, H.; Jim, H.; Dicker, A.; Dorff, T.; Moslehi, J.; Mucci, L.; Parsons, JK.; Saad, F.; Soule, H.; Morgans, A.; Ryan, CJ.: Improving Research for Prostate Cancer Survivorship: A Statement from the SuRECaP (Survivorship Research in Prostate Cancer) Working Group. Urologic Oncology: Seminars and Original Investigations 38(3): 83-93, Mar 2020.

Narayan, V.; Puligandla, M.; Haas, NB.; Subramanian, P.; DiPaola, RS.; Uzzo, R.: Patterns of Relapse and Implications for Post-Nephrectomy Surveillance for Patients with High-Risk Non-Clear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 Trial. J Urol 201(1): 62-68, Jan 2019.

Narayan, V.; Vapiwala, N.; Mick, R.; Subramanian, P.; Christodouleas, J.; Bekelman, J.; Deville, C.; Rajendran, R.; Haas, NB.: Phase I Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy. Int J Radiat Oncol Biol Phys 97(2): 355-361, Feb 2017.

Jung, IY.; Bartoszek, RL.; Rech, AJ.; Collins, SM.; Ooi, SK.; Williams, EF.; Hopkins, CR.; Narayan, V.; Haas, NB.; Frey, NV.; Hexner, EO.; Siegel, DL.; Plesa, G.; Porter, DL.; Cantu, A.; Everett, JK.; Guedan, S.; Berger, SL.; Bushman, FD.; Herbst, F.; Fraietta, JA.: Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T cell-intrinsic Dysfunction. Cancer Discov 13(7): 1636-1655, Jul 2023.

Jung, IY.; Narayan, V.; McDonald, S.; Rech, AJ.; Bartoszek, R.; Hong, G.; Davis, MM.; Xu, J.; Boesteanu, AC.; Barber-Rotenberg, JS.; Plesa, G.; Lacey, SF.; Jadlowsky, JK.; Siegel, DL.; Hammill, DM.; Cho-Park, PF.; Berger, SL.; Haas, NB.; Fraietta, JA.: BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion. Sci Transl Med 14(670): doi: 10.1126/scitranslmed.abn7336. Nov 2022.

Schram, AM.; Colombo, N.; Arrowsmith, E.; Narayan, V.; Yonemori, K.; Scambia, G.; Zelnak, A.; Bauer, TM.; Jin, N.; Ulahannan, SV.; Colleoni, M.; Aftimos, P.; Donoghue, M.; Rosen, E.; Rudneva, V.; Telli, ML.; Domchek, SM.; Galsky, M.; Hoyle, M.; Chappey, C.; Stewart, R.; Blake-Haskins, JA.; Yap, TA. : Avelumab Plus Talazoparib in BRCA1/2- or ATM-Altered Advanced Solid Tumors (JAVELIN BRCA/ATM): Results From an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial. JAMA Oncology 17(1): e225218, Nov 2022.

Narayan, V.; Ross, AE.; Parikh, RB.; Nohria, A.; Morgans, AK.: How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk: A Therapeutic Tightrope. J Am Coll Cardiol CardioOnc 3(5): 737-741, Dec 2021.

Narayan, V.: Comparing Cardiovascular Outcomes with Degarelix or Leuprolide as Prostate Cancer Therapy -- Applying Real-World Data to Clinical Trial Emulation. JAMA Netw Open 4(10): e2131429. Oct 2021.

Sun, L.; Parikh, RB.; Hubbard, R.; Cashy, J.; Takvorian, SU.; Vaughn, DJ.; Robinson, KW.; Narayan, V.*; Ky, B*.: Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer. JAMA Netw Open 4(2): e210070, Feb 2021 Notes: *Co-Senior Authors.

Ravi, P.; Mantia, C.; Su, C.; Sorenson, K.; Elhag, D.; Rathi, N.; Bakouny, Z.; Agarwal, N.; Zakharia, Y.; Costello, BA.; McKay, RR.; Narayan, V.; Alva, A.; McGregor, BA.; Gao, X.; McDermott, DF.; Choueiri, TK.: Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma. JAMA Oncology 6(10): 1606-1610, Oct 2020.

Narayan, V.; Thompson, EW.; Demissei, B.; Ho, JE.; Januzzi, JL.; Ky, B.: Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease. J Am Coll Cardiology. (eds.). 75(21): 2726-2737, Jun 2 2020.

Chanzá, NM.; Xie, W.; Bilen, MA.; Dzimitrowicz, H.; Burkart, J.; Geynisman, DM.; Balakrishnan, A.; Bowman, IA.; Jain, R.; Stadler, W.; Zakharia, Y.; Narayan, V.; Beuselinck, B.; McKay, R.; Tripathi, A.; Pachynski, R.; Hahn, AW.; Hsu, J.; Shah, SA.; Lam, ET.; Rose, TL.; Mega, AE.; Vogelzang, N.; Harrison, MR.; Mortazavi, A.; Plimack, ER.; Vaishampayan, U.; Hammers, H.; George, S.; Haas, N.; Agarwal, N.; Pal, SK.; Srinivas, S.; Carneiro, BA.; Heng, D.; Bosse, D.; Choueiri, T.; Harshman, LC. : Cabozantinib in advanced non-clear cell renal carcinoma: a multicenter retrospective cohort analysis. Lancet Oncol 20(4): 581-590, April 2019.

Narayan, V.; Ky, B.: Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention. Annu Rev Med 69(1): 97-111, Jan 2018.

Finkelman, BS., Putt, M., Wang, T., Wang, L., Narayan, H., Domchek, S., DeMichele, A., Fox, K., Matro, J., Shah, P., Clark, A., Bradbury, A., Narayan, V., Carver, J., Tang, WH., Ky, B.: Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients with Breast Cancer. J Am Coll Cardiology 70(2): 152-162, July 2017.

Narayan, V., Haas, N.: Axitinib in the treatment of renal cell carcinoma: patient selection and perspectives. Int J Nephrol 9: 65-72, Mar 2016.

Eule, CJ.; Hu, J.; Al-Saad, S.; Collier, K.; Boland, P.; Lewis, AR.; McKay, RR.; Narayan, V.; Bosse, D.; Mortazavi, A.; Rose, TL.; Costello, BA.; Bryce, AH.; Lam, E. : Outcomes of Second-Line Therapies in Patients with Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study. Clin Genitourin Cancer 21(4): 483-490, Aug 2023.

Demissei, B.; Finkelman, B.; Hubbard, RA.; Zhang, L.; Smith, AM.; Sheline, K.; McDonald, C.; Narayan, HK.; Narayan, V.; Waxman, AJ.; Domchek, S.; DeMichele, A.; Shah, P.; Clark, A.; Bradbury, A.; Carver, J.; Upshaw, J.; Armenian, SH.; Liu, P.; Ky, B. : Detailed Phenotyping Reveals Distinct Trajectories of Cardiovascular Function and Symptoms with Exposure to Modern Breast Cancer Therapy. Cancer 125(16): 2762-2771, Aug 2019.

Mohiuddin, J.; Narayan, V.; Venigalla, S.; Vapiwala, N. : Variations in patterns of concurrent androgen deprivation therapy use based on dose escalation with external beam radiotherapy vs. brachytherapy boost for prostate cancer. Brachytherapy 18(3): 322-331, May 2019.

Narayan, V.; Gunnarsson, O.; Hwang, WT.; Nathanson, KL.; Stadtmauer, EA.; Vaughn, DJ.: Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumor. Clin Genitourin Cancer 14(6): 524-529, Dec 2016.

Narayan, V.; Mamtani, R.; Keefe, S.; Guzzo, T.; Malkowicz, SB.; Vaughn, DJ.: A Phase II Study of Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer. Cancer Res Treat 48(3): 1084-91, July 2016.

Breen, KE.; Symecko, H.; Spielman, K.; Gebert, R.; Shah, IH.; Pundock, S.; Batson, M.; Narayan, V.; Stadler, Z.; Autio, KA.; Abida, W.; Danila, DC.; Scher, HS.; Morris, M.; Hamilton, JG.; Robson, ME.; Domchek, SM.; Carlo, MI.: Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients. J Urol 209(5): 918-27, May 2023.

Pain, DJ.; Takvorian, SU.; Narayan, V.: Disparities in Clinical Care and Research in Renal Cell Carcinoma. Kidney Cancer 6(3): 147-157, July 2022.

Barrett, M.; Wilcox, NS.; Huang, A.; Levy, R.; Demissei, B.; Narayan, V.; Ky, B.: Bearing Allostatic Load: Insights into a More Equitable Future Within Cardio-Oncology. Trends Mol Medic 28(12): 1040-1049, Dec 2022.

Lee, DJ.; Hausler, R.; Le, AN.; Kelly, G.; Powers, J.; Ding, J.; Feld, E.; Desai, H.; Morrison, C.; Doucette, A.; Gabriel, P.; Regeneron Genetics Center; Judy, RL.; Weaver, J.; Kember, R.; Damrauer, SM.; Rader, DJ.; Domchek, SM.; Narayan, V.; Schwartz, LE.; Maxwell, KN. : Association of inherited mutations in DNA repair genes with localized prostate cancer Eur Urol 81(6): 559-567, Jun 2022.

Hamilton, JG.; Symecko, H.; Spielman, K.; Breen, K.; Mueller, R.; Catchings, A.; Trottier, M.; Salo-Mullen, EE.; Shah, I.; Arutyunova, A.; Batson, M.; Gebert, R.; Pundock, S.; Schofield, E.; Offit, K.; Stadler, ZK.; Cadoo, K.; Carlo, MI.; Narayan, V.; Reiss, KA.; Robson, ME.; Domchek, SM.: Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer. Genet Med 23(11): 2105-2113, Nov 2021.

Morris, MJ.; Rowe, S.; Gorin, MA.; Saperstein, L.; Pouliot, F.; Josephson, DY.; Wong, JYC.; Pantel, AR.; Cho, SY.; Gage, KL.; Piert, MR.; Iagaru, A.; Pollard, JH.; Wong, V.; Jensen, J.; Lin, T.; Stambler, N.; Carroll, P.; Siegel, BA.; Wibmer, AG.; Durack, JC.; Solomon, SB.; Harb, R.; Pucar, D.; Sprenkle, P.; Beauregard, JM.; Beaulieu, A.; Buteau, FA.; Yamauchi, D.; Glaser, S.; Dorff, T.; Narayan, V.; Fillare, MA.; Schubert, E.; Cooley, G.; Morris, ZS.; Langeland, M.; Pow-Sang, JM.; Yamoah, K.; Alva, A.; Reichert, Z.; Spratt, D.; Davidzon, G.; Aparici, CM.; Moradi, F.; Tracy, C.; Behr, S.; Nguyen, HG.; Simko, JP.; Jennings, JW.; Michalski, JM.; Pachynski, RK.: Diagnostic Performance of 18 F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase 3, Multicenter Study. Clin Cancer Res 27(13): 3674-3682, Feb 2021 Notes: CONDOR Study Group.

Narayan, V.; Morgans, AK.: Duration of Androgen Deprivation Therapy and Cardiovascular Fitness: Right Patient, Right Therapy, Right Time. JACC: CardioOncol 2(4): 564-566, Nov 2020.

Demissei BG; Finkelman B; Hubbard RA; Smith AM; Narayan HK; Narayan V; Shah P; Waxman AJ; Domchek SM; Ky B.: Cardiovascular Function Phenotypes in Response to Cardiotoxic Breast Cancer Therapy. J Am Coll Cardiology 73(2): 248-249, Jan 2019.

Zhang, KW; Finkelman, BS; Gulati, G; Narayan, HK; Upshaw, J; Narayan, V; Plappert, T; Englefield, V; Smith, AM; Zhang, C; Hundley, WG; Ky B.: Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction. JACC Cardiovasc Imaging 11(8): 1059-1068, Aug 2018.

Narayan, V.; Hwang, WT.; Lal, P.; Rosen, M.; Gallagher, M.; O'Dwyer, P.; Vaughn, DJ.: Cyclin-Dependent Kinase 4/6 Inhibition for the Treatment of Mature Teratoma: Long-term Follow-up of a Phase II Study. Clin Genitourin Cancer 14(6): 504-510, Dec 2016.

Narayan, V.; Deshpande, C.; Bermudez, CA.; Golato, JM.; Lee, J.; Diamond, J.; Vaughn, DJ.: Bilateral Lung Transplantation for Bleomycin-Associated Lung Injury. Oncologist 22(5): 620-622, May 2017.

Narayan, V.; Vaughn, D.: Pharmacokinetic and toxicity considerations in the use of neoadjuvant chemotherapy for bladder cancer. Expert Opin Drug Metab Toxicol 11(5): 731-42, May 2015.

Else, T.; Jonasch, E.; IIiopoulos, O.; Beckermann, KE.; Narayan, V.; Maughan, BL.; Oudard, S.; Maranchie, JK.; Iversen, AB.; Goldberg, CM.; Fu, W.; Perini, RF.; Liu, Y.; Linehan, WM.; Srinivasan, R. : Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study. Clin Cancer Research Jan 2024 Notes: In Press.

Narayan, V.; Liu, T.; Song, Y.; Mitchell, J.; Sicks, J.; Gareen, I.; Sun, L.; Denduluri, S.; Fisher, C.; Manikowski, J.; Wojtowicz, M.; Vadakara, J.; Haas, N.; Margulies, K.; Ky, B.: Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Renal Cell Carcinoma and Thyroid Cancer Patients Treated with VEGFR Tyrosine Kinase Inhibitors. J Natl Compr Canc Netw 21(10): DOI: https://doi.org/10.6004/jnccn.2023.7047, Oct 2023.

Marar, M.; Long, Q.; Mamtani, R.; Narayan, V.; Vapiwala, N.; Parikh, RB. : Outcomes Among African American and Non-Hispanic White Men With Metastatic Castration-Resistant Prostate Cancer With First-Line Abiraterone. JAMA Netw Open 5(1): e2142093, Jan 2022.

Bratslavsky, G.; Mendhiratta, N.; Daneshvar, M.; Brugarolas, J.; Ball, MW.; Metwalli, A.; Nathanson, KL.; Pierorazio, P.; Boris, RS.; Singer, EA.; Carlo, MI.; Daly, MB.; Henske, EP.; Hyatt, C.; Middleton, L.; Morris, G.; Jeong, A.; Narayan, V.; Rathmell, WK.; Vaishampayan, U.; Lee, BL.; Battle, D.; Hall, MJ.; Hafez, K.; Jewett, MAS.; Karamboulas, C.; Pal, SK.; Hakimi, AA.; Kutikov, A.; Iliopoulos, O.: Linehan, WM.; Jonasch, E.: Genetic Risk Assessment for Hereditary Renal Cell Carcinoma: Clinical Consensus Statement. Cancer 127(21): 3957-3966, Nov 2021.

Feld, E.; Harton, J.; Meropol, NJ.; Adamson, BJS.; Cohen, A.; Parikh, RB.; Galsky, MD.; Narayan, V.; Christodouleas, J.; Vaughn, DJ.; Hubbard, RA.; Mamtani, R.: Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer. Eur Urol 76(4): 524-532, Oct 2019.

Narayan, V.; Vaughn, DJ.; Ky, B.: Cardiovascular Toxicities of Therapy for Genitourinary Malignancies. Urologic Oncology: Seminars and Original Investigations 38(3): 121-128, Mar 2020.

Narayan, V.; Gladney, W.; Plesa, G.; Vapiwala, N.; Carpenter, E.; Maude, SL.; Lal, P.; Lacey, S.; Melenhorst, J.; Sebro, R.; Farwell, M.; Hwang, WT.; Moniak, M.; Gilmore, J.; Lledo, L.; Dengel, K.; Marshall, A.; Coughlin, C.; June, CH.; Haas, NB.: A phase I clinical trial of PSMA-directed/TGFβ-insensitive CAR-T cells in metastatic castration-resistant prostate cancer. American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco, CA J Clin Oncol 37(suppl 7S; abstr TPS347), Feb 2019 Notes: "Oral Presentation"

Osterman, CK.; Alanzi, J.; Lewis, JD.; Kaufman, EL.; Narayan, V.; Boursi, B.; Vajravelu, RK.; Scott, FI.; Malkowicz, SB.; Mamtani, R.: Association Between Symptomatic Versus Asymptomatic Recurrence and Survival in Bladder Cancer. Clin Genitourin Cancer 16(3): 235-239, Jun 2018.

Parikh, RB.; Gallo, JJ.; Wong. Y.; Robinson, KW.; Cashy, JP.; Narayan, V.; Jayadevappa, R.; Chhatre, S.: Long-term depression incidence and associated mortality among African American and White prostate cancer survivors. Cancer 127((18)): 3476-3485, Sep 2021.

Osterman, CK.; Babu, DS.; Geynisman, D.; Lewis, B.; Somerd, RA.; Balar, AV.; Zibelman, MR.; Guancial, EA.; Antinori, G.; Yu, S.; Narayan, V.; Guzzo, TJ.; Plimack, ER.; Vaughn, DJ.; Fung, C.; Mamtani, R.: Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer. Oncologist 24(5): 688-90, May 2019.

Catino, AB; Hubbard, RA; Chirinos, JA; Townsend, R; Keefe, S; Haas, NB; Puzanov, I; Fang, JC; Agarwal, N; Hyman, D; Smith, AM; Gordon, M; Plappert, T; Englefield, V; Narayan, V; Ewer, S; ElAmm, C; Lenihan, D; Ky, B.: Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma. Circ Heart Fail 11(3): e004408, Mar 2018.

Zorko, NA.; Makovec, A.; Elliott, A.; Kellen, S.; Lozada, JR.; Arafa, AT.; Felices, M.; Shackelford, M.; Barata, P.; Zakharia, Y.; Narayan, V.; Stein, MN.; Zarrabi, KK.; Patniak, A.; Bilen, MA.; Radovich, M.; Sledge, G.; El-Deiry, WS.; Heath, EI.; Hoon, DSB.; Nabhan, C.; Miller, JS.; Hwang, JH.; Antonarakis, ES.: Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate Cancer and Prostatic Diseases Jan 2024 Notes: In Press.

Zarrabi, KK.; Narayan, V.; Mille, PJ.; Zibelman, MR.; Miron, B.; Bashir, B.; Kelly, WK.: Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer. Ther Adv Urol 15(17562872231182219), Jun 2023.

Li, L.; Huang, L.; Vergis, A.; Ye, H.; Bajwa, A.; Narayan, V.; Strieter, R.; Rosin, D.; Okusa, M. : IL-17 produced by neutrophils regulates interferon gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 120(1): 331-42, Jan 2010.

Lin, JK.; Hearn, CM.; Getzen, E.; Long, Q.; Lee, DC.; Keaveny, TM.; Jayadevappa, R.; Robinson, KW.; Wong, YN.; Maxwell, KN.; Narayan, V.; Haas, NB.; Takvorian, SU.; Bikle, DD.; Chiang, JM.; Khan, AN.; Rajapakse, CS.; Morgans, AK.; Parikh, RB.: Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer. Eur Urol Oncol S2588-9311(23)00230-4, Nov 2023.

Hahn, VS.; Zhang, KW.; Sun, L.; Narayan, V.; Lenihan, DJ.; Ky, B.: Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection. Circ Res 128(10): 1576-1593, May 2021.

Hwang, A.; Narayan, V.; Yang, YX.: Type 2 Diabetes Mellitus and Survival in Pancreatic Adenocarcinoma: A Retrospective Cohort Study. Cancer 119(2): 404-10, Jan 2013.

Demissei, B.; Hubbard, RA.; Zhang, L.; Smith, AM.; Sheline, K.; McDonald, C.; Narayan, V.; Domchek, SM.; DeMichele, A.; Shah, P.; Clark, AS.; Fox, K.; Matro, J.; Bradbury, AR.; Knollman, H.; Getz, KD.; Armenian, SH.; Januzzi, JL.; Tang, W.; Liu, P.; Ky, B.: Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction. J Am Heart Assoc 9(2): e014708, Jan 2020.

Narayan, V.: Metastatic Prostate Cancer. Radiation Oncology: A Question Based Review. Wolters Kluwer, 3rd Edition, Sep 2018.

Taku, N.; Narayan, V.; Wang, X.; Vapiwala, N.: Prevalence, predictors, and implications for appropriate use of active surveillance management among black men diagnosed with low-risk prostate cancer. Am J Clin Oncol 42(6): 507-511, Jun 2019.

Chao, HH.; Feld, EK.; Narayan, V.; Sebro, R.; Jones, JA.: Radiation Recall Myositis Following Carboplatin/Docetaxel Chemotherapy. Pract Radiat Oncol 10(1): e50-e52. Jan 2020.

Demissei, B.; Adusumalli, S.; Hubbard, RA.; Denduluri, S.; Narayan, V.; Clark, A.; Shah, P.; Knollman, H.; Getz, KD.; Aplenc, R.; Carver, JR.; Ky, B.: Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab. JACC: CardioOncology 2(2): 179-189, Jun 2020.

Yu, S.; Le, A.; Feld, E.; Schriver, E.; Gabriel, P.; Doucette, A.; Narayan, V.; Feldman, M.; Schwartz, L.; Maxwell, K.; Mowery, D.: A Natural Language Processing-Assisted Extraction System for Gleason Scores: Development and Usability Study. JMIR Cancer 7(3): e27970, Jul 2021.

Thompson, EW.; Demissei, BG.; Smith, AM.; Brahmbhatt, P.; Wang, J.; Clark, A.; DeMichele, A.; Narayan, V.; Shah, P.; Sun, L.; Lefebvre, B.; Fradley, MG.; Carver, JR.; Tang, WHW.; Ky, B.: Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab. JACC Basic Transl Sci 7(1): 1-10, Dec 2021.

Herrera, CD.; Guerra, CE.; Narayan, V.; Guzzo, TJ.; Mamtani, R.; Lee, DJ.; Tasian, GE.; Talwar, R. : Financial toxicity in prostate cancer survivors: A national cross-sectional assessment of subjective financial burden. Urologic Oncology: Seminars and Original Investigations S1078-1439(22): 00395-7, Nov 2022.

Narayan, V.; Jonasch, E.: Systemic Therapy Development in Von Hippel–Lindau Disease: An Outsized Contribution from an Orphan Disease. Cancers 14(21): 5313, Oct 2022.

Duarte, D.; Hu, J.; Beuselinck, B.; Panian, J.; Weise, N.; Dizman, N.; Collier, KA.; Rathi, N.; Li, H.; Elias, R.; Martinez-Chanza, N.; Rose, TL.; Harshman, LC.; Gopalakrishnan, D.; Vaishampayan, U.; Zakharia, Y.; Narayan, V.; Carneiro, BA.; Mega, A.; Singla, N.; Meguid, C.; George, S.; Brugarolas, J.; Agarwal, N.; Mortazavi, A.; Pal, S.; McKay, RR.; Lam, ET.: Metastatic renal cell carcinoma to the pancreas and other sites — a multicenter retrospective study. eClinMed 60( 102018), Jun 2023.

Orlovskiy, S.; Gupta, PK.; Roman, J.; Arias-Mendoza, F.; Nelson, DS.; Koch, CJ.; Narayan, V.; Putt, ME.; Nath, K.: Lonidamine Induced Selective Acidification and De-Energization of Prostate Cancer Xenografts: Enhanced Tumor Response to Radiation Therapy. Cancers 16(7): 1384, March 2024 Notes: doi: 10.3390/cancers16071384.